OSCR vs SARO
Comparison between Oscar Health Inc - Class A (OSCR, Company) and StandardAero Inc (SARO, Company).
OSCR is from the Healthcare sector, while SARO is from the Industrials sector.
OSCR vs SARO - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
OSCR
$9.13B
Winner
SARO
$9.15B
Max Drawdown
OSCR
94.15%
Winner
SARO
32.58%
Sharpe Ratio
Winner
OSCR
1.29
SARO
-0.23
5Y Beta
Winner
OSCR
1.05
SARO
1.13
Industry
OSCR
Healthcare Plans
SARO
Aerospace & Defense
P/E Ratio
Winner
OSCR
15.71
SARO
31.23
Forward P/E
OSCR
588.24
Winner
SARO
19.42
PEG Ratio
Winner
OSCR
0.05
SARO
0.11
Debt to Equity
Winner
OSCR
25.90%
SARO
82.16%
Free Cash Flow Yield
Winner
OSCR
31.06%
SARO
1.62%
OSCR vs SARO - Historical Returns
Returns include dividend reinvestment.
1M
Winner
OSCR
+1.05%
SARO
-0.78%
3M
Winner
OSCR
+84.64%
SARO
+2.35%
6M
Winner
OSCR
+74.38%
SARO
-18.04%
1Y
Winner
OSCR
+88.01%
SARO
-12.06%
5Y(CAGR)
OSCR
+8.29%
SARO
N/A
Max(CAGR)
Winner
OSCR
-3.43%
SARO
-10.96%
OSCR vs SARO - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | OSCR | SARO |
|---|---|---|
| 2026 | +92.79% | -10.19% |
| 2025 | +6.05% | +16.87% |
| 2024 | +47.69% | -24.40% |
| 2023 | +271.95% | N/A |
| 2022 | -69.74% | N/A |
| 2021 | -77.44% | N/A |
OSCR vs SARO Drawdown Comparison
The maximum drawdown for OSCR was -94.15%, occurring on Dec 21, 2022. This drawdown has not yet recovered.
The maximum drawdown for SARO was -32.58%, occurring on Apr 8, 2025. Recovery took 328 trading sessions.
The current OSCR drawdown is -21.51%. The current SARO drawdown is -19.63%.
| Rank | OSCR | SARO |
|---|---|---|
| #1 | -94.15% Mar 10, 2021 - Dec 21, 2022 | -32.58% Oct 3, 2024 - Jan 27, 2026 |
| #2 | -10.92% Mar 3, 2021 - Mar 10, 2021 | -26.51% Jan 27, 2026 - Apr 23, 2026 |
Correlation
Correlation between OSCR and SARO is 0.15 which considered as a very weak or no correlation - the stocks move independently of each other.
0.15
-101
Select Stocks to Compare
Popular: OSCR vs SPYSARO vs SPY
More Comparisons
Compare with similar stocks